Medicare Enrolled

Dr. Douglas Kelling, MD

Pulmonary Disease · Concord, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
200 MEDICAL PARK DR, Concord, NC 28025
7044031307
In practice since 2006 (20 years)
NPI: 1396717708 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kelling from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kelling? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kelling

Dr. Douglas Kelling is a pulmonary disease specialist in Concord, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kelling performed 3,977 Medicare services across 831 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kelling received a total of $126,358 from 24 pharmaceutical and/or device companies across 316 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kelling is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 6% volume in NC $126,358 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,977
Medicare services
Top 6% in NC for pulmonary disease
831
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~199 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 2,520 $18 $76
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
653 $86 $310
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
229 $65 $220
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
119 $16 $68
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
102 $10 $47
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
75 $125 $328
Prothrombin time test (blood clotting)
A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process.
73 $4 $17
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
53 $71 $152
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
53 $29 $50
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
45 $10 $75
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
41 $24 $120
COVID-19 amplified DNA/RNA probe detection
A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen.
14 $50 $167
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$126,358
Total received (2018-2024)
Avg $18,051/year across 7 years
Top 3% in NC for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
316
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$107,904 (85.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$14,886 (11.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,568 (2.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$877
2023
$144
2022
$2,728
2021
$9,410
2020
$14,206
2019
$56,459
2018
$42,534

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Insulet Corporation
$249
Lilly USA, LLC
$214
PFIZER INC.
$135
Novo Nordisk Inc
$89
GlaxoSmithKline, LLC.
$55
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
E.R. Squibb & Sons, L.L.C.
$37
Dynavax Technologies Corporation
$19
Merck Sharp & Dohme LLC
$17
Novartis Pharmaceuticals Corporation
$15
Top 3 companies account for 68.2% of 2024 payments
All-time payments by company (2018-2024) ›
Mylan Specialty L.P.
$32,151
Regeneron Healthcare Solutions, Inc.
$19,102
Sunovion Pharmaceuticals Inc.
$15,260
SANOFI PASTEUR INC.
$9,734
GlaxoSmithKline, LLC.
$8,551
AstraZeneca Pharmaceuticals LP
$8,261
Amgen Inc.
$6,551
Sanofi Pasteur Inc.
$5,472
Teva Pharmaceuticals USA, Inc.
$4,359
E.R. Squibb & Sons, L.L.C.
$4,226
ViiV Healthcare Company
$3,489
Novo Nordisk Inc
$2,665
GENZYME CORPORATION
$2,111
Novartis Pharmaceuticals Corporation
$2,009
Genentech USA, Inc.
$1,455
Insulet Corporation
$249
Lilly USA, LLC
$235
PFIZER INC.
$218
Boehringer Ingelheim Pharmaceuticals, Inc.
$77
Boston Scientific Corporation
$74
Merck Sharp & Dohme LLC
$37
SANOFI-AVENTIS U.S. LLC
$29
CSL Behring
$24
Dynavax Technologies Corporation
$19
Top 3 companies account for 52.6% of all-time payments
Associated products mentioned in payments ›
ANORO · AREXVY · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CINQAIR · DUPIXENT · ELIQUIS · ENTRESTO · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT · FLUZONE HIGH-DOSE · GARDASIL · Heplisav-B · JARDIANCE · LEQVIO · LOKELMA · LONHALA MAGNAIR · LYRICA · MOUNJARO · NUCALA · NURTEC ODT · Omnipod · Ozempic · PRALUENT ALIROCUMAB INJECTION · RYBELSUS · Repatha · Rybelsus · SHINGRIX · Saxenda · TRELEGY ELLIPTA · WATCHMAN · Wegovy · Xolair · YUPELRI · Yupelri · Zemaira
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (85%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for pulmonary disease in NC.

Looking for a pulmonary disease specialist in Concord?
Compare pulmonary diseases in the Concord area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
27
Per 100K population
11.7
County median income
$86,084
Nearest hospital
CAROLINAS MEDICAL CENTER-NORTHEAST
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kelling is a clinical cardiology specialist, with above-average Medicare volume (top 6% in NC), with speaking/promotional industry engagement in the top 3% of NC peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kelling experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Kelling performed 2,520 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kelling receive payments from pharmaceutical companies?
Yes. Dr. Kelling received a total of $126,358 from 24 companies across 316 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kelling's costs compare to other pulmonary diseases in Concord?
Dr. Kelling's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kelling) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →